AstraZeneca’s new antibiotic Zavicefta approved in the EU
The European Commission (EC) has granted marketing authorisation for AstraZeneca’s combination antibiotic Zavicefta (ceftazidime-avibactam) for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation.
Click on this link for more information.
